{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:06:39Z","timestamp":1789416399255,"version":"build-2803163510"},"reference-count":42,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>\n                      Neurotrophic tropomyosin receptor kinase (\n                      <jats:italic toggle=\"yes\">NTRK<\/jats:italic>\n                      ) fusions may act as an oncogenic driver in thyroid carcinomas. Given their low frequency, clinical, pathological, and molecular data on these patients and their responses to targeted therapies are limited.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This is an observational retrospective study conducted at a single high-volume cancer center in the United States. Data were retrospectively collected from medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      We included 65 patients (37 adult, 28 pediatric) with an\n                      <jats:italic toggle=\"yes\">NTRK<\/jats:italic>\n                      fusion\u2013positive thyroid carcinoma (24\n                      <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                      , 41\n                      <jats:italic toggle=\"yes\">NTRK3<\/jats:italic>\n                      ), of which 54 were papillary thyroid carcinomas (PTC), four poorly differentiated thyroid carcinomas (PDTC), and seven anaplastic thyroid carcinomas (ATC). In PTC, an extensive follicular growth pattern was seen in 22 (41%) patients. In adults,\n                      <jats:italic toggle=\"yes\">NTRK3<\/jats:italic>\n                      fusions were 3 times more frequent (nine\n                      <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                      , 28\n                      <jats:italic toggle=\"yes\">NTRK3<\/jats:italic>\n                      ), whereas in pediatric patients their frequencies were similar (15\n                      <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                      , 13\n                      <jats:italic toggle=\"yes\">NTRK3<\/jats:italic>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .021). In patients with PDTC\/ATC treated with larotrectinib, we detected four emergent solvent front mutations (three\n                      <jats:italic toggle=\"yes\">NTRK3<\/jats:italic>\n                      G623R, one\n                      <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                      G595R) causing resistance to drug and disease progression. Three of them (two ATC, one PDTC) received second-line selitrectinib on a clinical trial. Partial responses were seen in all three patients, but both patients with ATC progressed within a year.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                      \/\n                      <jats:italic toggle=\"yes\">3<\/jats:italic>\n                      fusions are seen in PTC, PDTC, and ATC, and a follicular growth pattern was observed in a high proportion of cases. In patients treated with larotrectinib,\n                      <jats:italic toggle=\"yes\">NTRK<\/jats:italic>\n                      solvent front mutations are the main resistance mechanism, frequently occurring in PDTC\/ATC. Responses to single-agent TRK inhibitor are short-lived in patients with ATC; thus, these drugs should be used with caution in this population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po.24.00321","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:59:11Z","timestamp":1740153551000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":13,"title":["<i>NTRK<\/i>\n                    Fusion\u2013Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-722X","authenticated-orcid":true,"given":"Vicente R.","family":"Marczyk","sequence":"first","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5181-6013","authenticated-orcid":true,"given":"Sasan","family":"Fazeli","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Dadu","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-6378","authenticated-orcid":true,"given":"Naifa L.","family":"Busaidy","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Iyer","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-030X","authenticated-orcid":true,"given":"Mimi I.","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3079-5153","authenticated-orcid":true,"given":"Steven I.","family":"Sherman","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-9885","authenticated-orcid":true,"given":"Sarah","family":"Hamidi","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3626-9928","authenticated-orcid":true,"given":"Sayed Mohsen","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-7332","authenticated-orcid":true,"given":"Michelle D.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmaan","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"Elzamly","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4860-261X","authenticated-orcid":true,"given":"Mark J.","family":"Routbort","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-0221","authenticated-orcid":true,"given":"Raja","family":"Luthra","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9447-7701","authenticated-orcid":true,"given":"Sinchita","family":"Roy-Chowdhuri","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Anthony","family":"San Lucas","sequence":"additional","affiliation":[{"name":"Clinical Bioinformatics, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5081-2427","authenticated-orcid":true,"given":"Keyur P.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8721-1609","authenticated-orcid":true,"given":"David S.","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7918-9739","authenticated-orcid":true,"given":"Mark","family":"Zafereo","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgery, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0807-3832","authenticated-orcid":true,"given":"Jennifer R.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgery, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-2841","authenticated-orcid":true,"given":"Anastasios","family":"Maniakas","sequence":"additional","affiliation":[{"name":"Department of Head &amp; Neck Surgery, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-0100","authenticated-orcid":true,"given":"Steven G.","family":"Waguespack","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-1811","authenticated-orcid":true,"given":"Maria E.","family":"Cabanillas","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09707-3"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.050"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0113-0"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.1379"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081932"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28555"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0373"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3165"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05134-x"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0574-4"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.5005"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0118-3"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0324-7"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0638-5"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-21-0061"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09648-9"},{"key":"e_1_3_6_18_2","article-title":"Real-world experience of NTRK fusion\u2013positive thyroid cancer","author":"Park JC","unstructured":"Park JC, Ashok A, Liu C, et al: Real-world experience of NTRK fusion\u2013positive thyroid cancer. JCO Precis Oncol 10.1200\/PO.21.00442","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0802"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2022.01.002"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144847"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.1655"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29887"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa935"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.2350\/15-07-1667-OA.1"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01861"},{"key":"e_1_3_6_27_2","article-title":"NTRK fusions identified in pediatric tumors: The frequency, fusion partners, and clinical outcome","author":"Zhao X","unstructured":"Zhao X, Kotch C, Fox E, et al: NTRK fusions identified in pediatric tumors: The frequency, fusion partners, and clinical outcome. JCO Precis Oncol 10.1200\/PO.20.00250","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3597"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30691-6"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714448"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30856-3"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-1259"},{"key":"e_1_3_6_33_2","first-page":"e220062","article-title":"Kinase inhibitors in thyroid cancers","volume":"3","author":"Sukrithan V","year":"2023","unstructured":"Sukrithan V, Jain P, Shah MH, et al: Kinase inhibitors in thyroid cancers. Endocr Oncol 3:e220062, 2023","journal-title":"Endocr Oncol"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0507"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0484"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11496-z"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2022.03.002"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.3104"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302299"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-21-P02-01"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1630"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2020.100108"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27025"}],"updated-by":[{"DOI":"10.1200\/po-25-00552","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000}}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO.24.00321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T19:59:17Z","timestamp":1752091157000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO.24.00321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1200\/PO.24.00321"],"URL":"https:\/\/doi.org\/10.1200\/po.24.00321","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2024-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400321"}}